Unknown NA INTERVENTIONAL 1-arm NCT03294746

Imaging Biomarker in Cancer Drug Induced ILD (ImageILD)

Qualification of Imaging Methods to Assess Cancer Drug Induced Interstitial Lung Disease (ImageILD)

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Drug Induced Interstitial Lung Disease (DIILD) Cancer Patients

Interventions Clinical evaluations Thoracic CT

Updated 6 times since 2017 Last updated: Sep 27, 2017 Started: Jan 31, 2018 Primary completion: Jul 31, 2021 Completion: Jul 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03294746, this NA trial focuses on Drug Induced Interstitial Lung Disease (DIILD) Cancer Patients and remains ongoing. Sponsored by European Organisation for Research and Treatment of Cancer - EORTC, it has been updated 6 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA
Jun 2018 — Jan 2021 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.